We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

Biotechnology
Acquirer Target Price
Axovant Sciences Ltd. Exclusive worldwide license to OXB-102 $30 million
Gilead Sciences, Inc. Exclusive license to 2 immunization technologies $10 million
Yakult Honsha Co., Ltd. Exclusive license to duvelisib in Japan $10 million
CStone Pharmaceuticals Exclusive license to avapritinib, BLU-554 & BLU-667 $40 million
Versartis, Inc. Aravive Biologics, Inc. Merger
ACON Investments and Humus Capital Partners Biosidus S.A. and Biosidus Farma S.A. N/A
eHealth
Acquirer Target Price
Teladoc, Inc. Advance Medical $352 million
Medical Devices
Acquirer Target Price
CoreLink, LLC Expanding Orthopedics, Inc N/A
Physician Medical Groups
Acquirer Target Price
Strategic Health Services, LLC Jay Care Medical Center, Inc. N/A
New Enterprise Associates, Inc. Paladina Health $100 million
Cranemere NorthStar Anesthesia N/A
Gryphon Investors Water’s Edge Dermatology N/A
Inception Fertility Ventures RMA of Texas N/A
Other
Acquirer Target Price
Mitchell International, Inc. Medical Consultants Network N/A
CORDENTAL Group Drs. Melman, Ravett & Associates N/A
CRYO-CELL International, Inc. Cord:Use Cord Blood Bank Inc. $14 million